Etienne Sollier

Etienne Sollier

Auto-generated profile, based on publicly available information

Etienne Sollier

Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
ESEtienne Sollier
Etienne Sollier
JKJack Kuipers
Jack Kuipers
KTKoichi Takahashi
Koichi Takahashi
NBNiko Beerenwinkel
Niko Beerenwinkel
KJKatharina Jahn
Katharina Jahn
Reconstructing the history of somatic DNA alterations can help understand the evolution of a tumor and predict its resistance to treatment. Single-cell DNA sequencing (scDNAseq) can be used to investigate clonal heterogeneity and to inform phylogeny reconstruction. However, most existing phylogenetic methods for scDNAseq data are designed either for single nucleotide variants (SNVs) or for large copy number alterations (CNAs), or are not applicable to targeted sequencing. Here, we develop COMPASS, a computational method for inferring the joint phylogeny of SNVs and CNAs from targeted scDNAseq data. We evaluate COMPASS on simulated data and apply it to several datasets including a cohort of 123 patients with acute myeloid leukemia. COMPASS detected clonal CNAs that could be orthogonally validated with bulk data, in addition to subclonal ones that require single-cell resolution, some of which point toward convergent evolution.

27 September 2024 in Blood Advances
Verified
Journal Article
Open access
PDF file
DWDieter Weichenhan
Dieter Weichenhan
ARAnna Riedel
Anna Riedel
ESEtienne Sollier
Etienne Sollier
UTUmut H. Toprak
Umut H. Toprak
JHJoschka Hey
Joschka Hey
CPChristoph Plass
Christoph Plass
Acute myeloid leukemia (AML) with the t(7;12)(q36;p13) translocation occurs only in very young children and has a poor clinical outcome. The expected oncofusion between break point partners (motor neuron and pancreas homeobox 1 [MNX1] and ETS variant transcription factor 6 [ETV6]) has only been reported in a subset of cases. However, a universal feature is the strong transcript and protein expression of MNX1, a homeobox transcription factor that is normally not expressed in hematopoietic cells. Here, we map the translocation break points on chromosomes 7 and 12 in affected patients to a region proximal to MNX1 and either introns 1 or 2 of ETV6. The frequency of MNX1 overexpression in pediatric AML is 2.4% and occurs predominantly in t(7;12)(q36;p13) AML. Chromatin interaction assays in a t(7;12)(q36;p13) induced pluripotent stem cell line model unravel an enhancer-hijacking event that explains MNX1 overexpression in hematopoietic cells. Our data suggest that enhancer hijacking may be a more widespread consequence of translocations in which no oncofusion product was identified, including t(1;3) or t(4;12) AML.

3 June 2024 in Bioinformatics
Verified
Journal Article
Open access
PDF file
ESEtienne Sollier
Etienne Sollier
JHJessica Heilmann
Jessica Heilmann
CGClarissa Gerhauser
Clarissa Gerhauser
MSMichael Scherer
Michael Scherer
CPChristoph Plass
Christoph Plass
PLPavlo Lutsik
Pavlo Lutsik
The vast amount of publicly available genomic data requires analysis and visualization tools. Here, we present figeno, an application for generating publication-quality FIgures for GENOmics. Figeno particularly focuses on multi-region views across genomic breakpoints and on long reads with base modifications. Additionally, we support epigenomic data including ATAC-seq, ChIP-seq or HiC, as well as whole genome sequencing data with copy numbers and structural variants. Figeno is available as a python package with both a command line and graphical user interface. It can be installed via PyPI and the source code is available at https://github.com/CompEpigen/figeno. Supplementary data are available at Bioinformatics online.

22 March 2023 in Leukemia
Verified
Journal Article
Open access
PDF file
DWDieter Weichenhan
Dieter Weichenhan
ARAnna Riedel
Anna Riedel
CMCharlotte Meinen
Charlotte Meinen
ABAlisa Basic
Alisa Basic
RTReka Toth
Reka Toth
CPChristoph Plass
Christoph Plass

31 March 2025 in Blood Cancer Discovery
Verified
Journal Article
Open access
ESEtienne Sollier
Etienne Sollier
ARAnna Riedel
Anna Riedel
UTUmut H. Toprak
Umut H. Toprak
JWJustyna A. Wierzbinska
Justyna A. Wierzbinska
DWDieter Weichenhan
Dieter Weichenhan
CPChristoph Plass
Christoph Plass
Acute myeloid leukemia (AML) with complex karyotype is characterized by high genomic complexity, including frequent TP53 mutations and chromothripsis. Genomic rearrangements can reposition active enhancers near proto-oncogenes, leading to their aberrant expression; however, a comprehensive understanding of these events in AML is still incomplete. To facilitate the discovery of such “enhancer hijacking” events, we developed Pyjacker, a computational tool, and applied it to 39 AML samples with complex karyotype. Pyjacker identified several enhancer hijacking events in AML patient samples, including aberrant expression of MNX1, which can result from del(7)(q22q36) and is associated with hijacking of a CDK6 enhancer. MNX1 activation occurred in 1.4% of patients with AML and showed significant co-occurrence with BCOR mutations. Through a xenograft mouse model, we demonstrated that MNX1 is required for leukemia cell fitness. Pyjacker is an easy-to-use, accurate, and broadly applicable tool for identifying consequences of genomic events driving tumorigenesis, especially when germline genomic data are missing. Significance: This study examines the consequences of structural alterations in AML and demonstrates that proto-oncogene activation by enhancer hijacking is an understudied pathomechanism. MNX1 overexpression demonstrates that deletions on chromosome 7q can not only lead to haploinsufficiency but also to activation of oncogenes by enhancer hijacking.

6 January 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
ESEtienne Sollier
Etienne Sollier
JKJack Kuipers
Jack Kuipers
KTKoichi Takahashi
Koichi Takahashi
NBNiko Beerenwinkel
Niko Beerenwinkel
KJKatharina Jahn
Katharina Jahn
Reconstructing the history of somatic DNA alterations can help understand the evolution of a tumor and predict its resistance to treatment. Single-cell DNA sequencing (scDNAseq) can be used to investigate clonal heterogeneity and to inform phylogeny reconstruction. However, most existing phylogenetic methods for scDNAseq data are designed either for single nucleotide variants (SNVs) or for large copy number alterations (CNAs), or are not applicable to targeted sequencing. Here, we develop COMPASS, a computational method for inferring the joint phylogeny of SNVs and CNAs from targeted scDNAseq data. We evaluate COMPASS on simulated data and apply it to several datasets including a cohort of 123 patients with acute myeloid leukemia. COMPASS detected clonal CNAs that could be orthogonally validated with bulk data, in addition to subclonal ones that require single-cell resolution, some of which point toward convergent evolution.